May 10, 2016 / 12:32 PM / a year ago

BRIEF-Pfizer Canada says Health Canada has given conditional approval of IBRANCE TM

May 10 (Reuters) - Pfizer Canada

* Health Canada has provided conditional approval of IBRANCE TM (palbociclib) and it is now available in canada Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below